SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " astorg " 8 found 🔀 AI-powered Shuffle
Sign in to save shuffle history.
Thermo Fisher to sell its microbiology business to Astorg for about $1.08 billion
April 27 () - Thermo Fisher Scientific said on Monday it has agreed to sell its microbiology business to a pan-European private equity firm Astorg for about $1.08 billion, consisting of cash and a $50 million seller note.
Astorg to Acquire Thermo Fisher Scientific Microbiology Business
Astorg, a pan-European private equity firm, signed a definitive agreement to acquire the microbiology business from Thermo Fisher Scientific.
Thermo Fisher Scientific sells microbiology business for $1B to European private equity firm
Thermo Fisher Scientific is shedding its microbiology business to private equity firm Astorg nearly a year after initial rumors of a sale surfaced. | Thermo Fisher Scientific is shedding its microbiology business to private equity firm Astorg nearly a year after rumors of a potential sale first surfaced.
Thermo Fisher to Sell Microbiology Business to Astorg
Thermo Fisher Scientific has struck a deal to sell its microbiology business to European private-equity firm Astorg for about $1.075 billion.
Astorg Acquires Thermo Fisher Microbiology Business, Forms Independent Company
Astorg has completed its acquisition of Thermo Fisher’s microbiology business, which will operate independently under CEO Dirk Bontridder.
Thermo Fisher to Sell Microbiology Business to Astorg
Thermo Fisher Scientific has struck a deal to sell its microbiology business to European private-equity firm Astorg for about $1.075 billion.
Thermo Fisher to sell its microbiology business to Astorg for about $1.08 billion
Thermo Fisher Scientific said on Monday it has agreed to sell its microbiology business to a pan-European private equity firm Astorg for about $1.08 billion, consisting of cash and a $50 million seller note.
Astorg buys Thermo Fisher Microbiology business
Astorg has agreed to acquire Thermo Fisher Scientific’s microbiology business, creating a standalone diagnostics platform backed by private equity investment.